The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
